![Page 1: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/1.jpg)
![Page 2: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/2.jpg)
![Page 3: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/3.jpg)
![Page 4: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/4.jpg)
![Page 5: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/5.jpg)
![Page 6: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/6.jpg)
![Page 7: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/7.jpg)
![Page 8: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/8.jpg)
NIAID Food Allergy ResearchConsortium of Food Allergy Research
Hugh Sampson, MD, Mount Sinai School of Medicine$16 million over five years – CoFAR$5 million over five years – SAC (EMMES)
Interventional ProjectClinical trial of a new food allergy immunotherapy
Observational ProjectNatural history study correlating new food allergy and tolerance to food with immunologic events
Basic Immunology ProjectMouse model of mechanisms of potential immune-based peanut allergy intervention
![Page 9: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/9.jpg)
NIAID Food Allergy ResearchConsortium of Food Allergy Research
Mount Sinai School of MedicineDuke University School of MedicineJohns Hopkins University School of MedicineNational Jewish Medical and Research CenterUniversity of Arkansas Children’s Hospital Research InstituteYale University School of Medicine
![Page 10: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/10.jpg)
![Page 11: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/11.jpg)
![Page 12: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/12.jpg)
![Page 13: PowerPoint Presentation · Mucosal Immunoprophylaxis (OMIP) Patrick Holt, RI. 200 high risk children age 18-30 months (FH of atopy, personal history of food allergy or atopic dermatitis)](https://reader034.vdocuments.mx/reader034/viewer/2022051801/5ade0ee67f8b9a595f8da14c/html5/thumbnails/13.jpg)